In 2019, ASCO recognizes the progress in treating rare cancers as the Advance of the Year. Impressive progress has been made in bringing new treatment advances to cancers that are rare and difficult to treat. This year’s Clinical Cancer Advances report describes emerging treatments for thyroid cancer, uterine cancer, desmoid tumor, neuroendocrine tumor, and tenosynovial giant cell tumor.
Cancer.Net Associate Editors discuss exciting and practice-changing cancer research from ASCO Annual Meeting in this Research Round Up podcast.
When Josh Mailman was diagnosed with a pancreatic neuroendocrine tumor, he didn’t expect his life to be defined by two of Dr. Seuss’ books—Did I Ever Tell You How Lucky You Are? and Oh, The Places You’ll Go. Now as a patient advocate, his goal is to ensure that others diagnosed with rare cancers do not need to rely on luck and travel to get the best outcome.